Objective: To determine whether small, incidentally detected testicular lesions can be safely followed up, by assessing growth rate and volume threshold for benign vs. malignant lesions.

Methods: This retrospective observational study includes a consecutive series of 130 testicular incidentalomas < 1 cm and with negative tumour markers identified from October 2001 to November 2022, which were initially followed up with ultrasound. A total of 39 cases proceeded to surgery during the study period, either due to lesion growth (n = 28) or patient preference/recommendation by the referring urologist (n = 11). For the lesions that were growing, specific growth rate (SGR) and doubling time (DT) were calculated assuming an exponential growth pattern. In addition, the velocity of increase of the average diameter (∆D) and of the maximum diameter (∆D) were calculated.

Results: Of the 130 nodules that were initially followed up, six disappeared, eight were reduced in size, eighty-eight were stable, and twenty-eight increased in size. For operated nodules all 18 malignant tumours, 8/9 benign tumours, and 2/12 surgically proved non-neoplastic lesions were growing. The best cut-off values of the growth indicators to differentiate between malignant and non-malignant histology were 3.47 × 10%volume/day, ≤ 179 days, > 10 × 10mm/day, and > 5 × 10mm/day for SGR, DT, ∆D, ∆D, respectively.

Conclusions: Malignant and non-malignant small incidentalomas can be effectively differentiated based on growing parameters, even though overlap exists. An increase of the maximum diameter of about 1 mm and 2 mm in three months and in six months, respectively, suggests malignancy.

Clinical Relevance Statement: Growing parameters allow an educated assessment of benign and malignant small testicular incidentalomas. Non-aggressive management is justified and safe when follow-up includes self-examination and tumour marker assessment to reduce the risk of interval tumour growth.

Key Points: Small, non-palpable and asymptomatic testicular nodules < 1 cm are unexpectedly discovered during scrotal ultrasound. Growth indicators estimate the potential malignancy, even though overlap with non-malignant lesions exists. Non-growing incidentalomas can be safely followed up.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-024-10981-4DOI Listing

Publication Analysis

Top Keywords

testicular incidentalomas
12
growth rate
8
malignant non-malignant
8
benign malignant
8
growing parameters
8
testicular
5
follow-up non-palpable
4
non-palpable testicular
4
incidentalomas
4
incidentalomas 1 cm
4

Similar Publications

Prostatic adenocarcinoma is characterized by elevated phosphatidylcholine metabolism. F-choline positron emission tomography/computed tomography (PET/CT) is widely used for patients with biochemical recurrence and a prostate-specific antigen threshold above 2 ng/mL. We report a case of a patient with high-risk prostatic adenocarcinoma undergoing F-choline PET/CT for biochemical recurrence.

View Article and Find Full Text PDF

Objective: To determine whether small, incidentally detected testicular lesions can be safely followed up, by assessing growth rate and volume threshold for benign vs. malignant lesions.

Methods: This retrospective observational study includes a consecutive series of 130 testicular incidentalomas < 1 cm and with negative tumour markers identified from October 2001 to November 2022, which were initially followed up with ultrasound.

View Article and Find Full Text PDF

Clinically functioning gonadotropin-secreting pituitary adenoma.

Endocrinol Diabetes Metab Case Rep

January 2024

Department of Internal Medicine, Endocrine and diabetes division, Adan Hospital, Kuwait.

Article Synopsis
  • Gonadotroph adenomas are the most common type of nonfunctional pituitary adenomas, but functioning ones that cause symptoms are quite rare; this article discusses a case of a 42-year-old man diagnosed with a functioning gonadotroph adenoma after an incidental finding of a pituitary mass.
  • The patient exhibited elevated follicle-stimulating hormone (FSH) and testosterone levels, underwent transsphenoidal resection of the adenoma, and subsequently saw normalization of hormone levels and improvement in symptoms.
  • The findings emphasize the importance of endocrine evaluation for pituitary incidentalomas, the diagnostic challenges posed by functioning gonadotroph adenomas, and the effectiveness of surgery in achieving favorable patient outcomes.
View Article and Find Full Text PDF

Context: Unlike palpable lumps, a large number of nonpalpable testicular lesions found incidentally at ultrasound in asymptomatic postpuberal males are either benign tumours or non-neoplastic lesions. The prevalence of malignancy, however, is appraised based on small case series. Dedicated studies report a large number of patients, and systematic review articles are lacking.

View Article and Find Full Text PDF

Incidental Findings and How to Manage Them: Testis- A WFUMB Position Paper.

Ultrasound Med Biol

October 2021

Department Allgemeine Innere Medizin, Kliniken Hirslanden Beau Site, Salem und Permanence, Bern, Switzerland. Electronic address:

Testicular incidentalomas are non-palpable, asymptomatic lesions, most frequently detected on ultrasound examinations. Each incidentaloma should undergo a standardized diagnostic workup to exclude malignancy and recognize other potentially significant non-malignant conditions that may first present with an incidental finding on scrotal ultrasound. This position statement of the World Federation of Ultrasound in Medicine and Biology (WFUMB) summarizes the available evidence on management of testicular incidentalomas and describes efficient management strategies with particular reference to the role of ultrasound techniques.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!